Research Article
Clinical Utility of Emergency Capsule Endoscopy for Diagnosing the Source and Nature of Ongoing Overt Obscure Gastrointestinal Bleeding
Table 2
Treatment methods for small-bowel lesions causing ongoing overt obscure gastrointestinal bleeding.
| | (%) |
| | Group A, , CE at ≤48 h | | Vascular lesion | 5 (33) | | Endoscopic hemostasis | 5 (33) | | Ulcerative lesion | 2 (13) | | Endoscopic hemostasis | 1 (7) | | Medication | 1 (7) | | Neoplastic lesion | 4 (27) | | Surgery | 2 (13) | | No treatment | 2 (13) | | Meckel’s diverticulum | 1 (7) | | No treatment | 1 (7) | | Group B, , CE at >48 h | | Vascular lesion | 24 (21) | | Endoscopic hemostasis | 23 (20) | | Surgery | 1 (1) | | Ulcerative lesion | 20 (18) | | Medication | 10 (9) | | Endoscopic hemostasis | 9 (8) | | Interventional radiology | 1 (1) | | Neoplastic lesion | 8 (7) | | Surgery | 6 (5) | | No treatment | 2 (2) | | Meckel’s diverticulum | 1 (1) | | Surgery | 1 (1) |
|
|
The patients were stratified according to the timing of CE relative to the onset of bleeding. Abbreviations: CE, capsule endoscopy.
|
